HOME
ABOUT US
PARTNERSHIPS
GALLERY
COURSES
OUR MOBILE APP
FORMS
CAREERS
CONTACT US

PARTNERSHIPS



DIOPTEX was founded in 2003, and it focuses on research, development, and marketing of new and innovative technologies for eye surgery.

DIOPTEX

GLOBAL LEADER IN CORNEAL TECHNOLOGY

INNOVATION IS OUR BUSINESS

HISTORY

OF DIOPTEX

2003: Dioptex GmbH was founded in 2003 by Dr. Albert Daxer as a research and developmental company to improve the treatment possibilities in keratoconus and difficult cases of myopia.  The project was financially supported by the AWS (Austria Wirtschaft Service), the support bank of the Republic of Austria for new and innovative technologies.

2006: Approval of PocketMaker Ultrakeratome as medical device in the EU.

2007: Approval of MyoRing as medical device in the EU.

2008 - 2014: Treatment trials in more than 20 countries around the world were performed to prove the safety and effectivity of the MyoRing-technology under routine conditions. These trials included more than 7000 eyes and were financially supported by the Austrian Research and Science Fund (FFG). The result is a mature treatment technology which allows the trained surgeon to achieve the best possible result in any give case. There is currently no treatment option of keratoconus being as effective and safe as CISIS/MyoRing.

2014: The International Keratoconus Centre was founded by Dr. Albert Daxer.

2017: Approval of Keralux as a medical device in the EU.

2018: Launch of Keralux.